Sudarshan Pharma Allots 48.11 Lakh Shares on FCCB Conversion

Sudarshan Pharma Industries Ltd announced the allotment of 48,11,730 fully paid-up equity shares following the conversion of Foreign Currency Convertible Bonds (FCCBs) worth USD 15,00,000. The allotment was approved by the FCCB Committee of the company on August 19, 2026. Each share has a face value of ₹1 and was issued at a price of ₹30.19, with a premium of ₹29.19 per share. This conversion increases the total issued and paid-up equity capital to ₹25,44,70,600, comprising 25,44,70,600 equity shares. The newly allotted shares are identical and rank pari-passu with existing equity shares.